Charlie Tobler

EVP, Chief New Products Officer at TerSera Therapeutics

Charlie Tobler is Executive Vice President, Commercial Operations of TerSera Therapeutics.

Previously, Charlie was the Head of Commercial Operations for Crealta Pharmaceuticals and Actient Pharmaceuticals.

Prior to Crealta and Actient, Charlie was Vice President and Franchise Leader for Takeda's Global Cardiovascular and Metabolic (CVM) franchise. In that role, he led strategic planning and business development targeting for Takeda's global CVM business. He also served as Vice President of Diabetes Marketing for Takeda Pharmaceuticals North America.

Prior to Takeda, he spent four years in marketing and business development at TAP Pharmaceuticals. Prior to TAP, he spent 14 years with Eli Lilly and Company, where he held various sales and marketing positions.

Charlie holds a B.S. Pharm. Degree in Pharmacy from the University of Iowa and an M.B.A. from The Kelley School of Business at Indiana University. Charlie is also a registered pharmacist.

Links


Org chart